Recognized for their ongoing dedication and pioneering approach to in-depth scientific research and innovative treatments for adults and children with rare adrenal disorders, the nationally and internationally recognized specialists in the OSUCCC – James Comprehensive Adrenal Program experts often share findings and accomplishments with medical experts from around the world through presentations and numerous national and international meetings and conferences.
Additionally, these researchers have described their scientific findings and successful outcomes in numerous publications including:
Evaluation and Treatment of Patients With Hypercortisolism: A Review. Miller BS, Auchus RJ. JAMA Surg. 2020 Dec 1;155(12):1152-1159. doi: 10.1001/jamasurg.2020.3280.PMID: 33052413.
Update on Pheochromocytoma and Paraganglioma From the SSO Endocrine and Head and Neck Disease Site Working Group, Part 2 of 2: Perioperative Management and Outcomes of Pheochromocytoma and Paraganglioma. Patel D, Phay JE, Yen TWF, Dickson PV, Wang TS, Garcia R, Yang AD, Kim LT, Solórzano CC. Ann Surg Oncol. 2020 May;27(5):1338-1347. doi: 10.1245/s10434-020-08221-2. Epub 2020 Feb 28. PMID: 32112213
Adjuvant Radiation Improves Recurrence-Free Survival and Overall Survival in Adrenocortical Carcinoma. Gharzai LA, Green MD, Griffith KA, Else T, Mayo CS, Hesseltine E, Spratt DE, Ben-Josef E, Sabolch A, Miller BS, Worden F, Giordano TJ, Hammer GD, Jolly S. J Clin Endocrinol Metab. 2019 Sep 1;104(9):3743-3750. doi: 10.1210/jc.2019-00029. PMID: 31220287
Longitudinal Patterns of Recurrence in Patients With Adrenocortical Carcinoma. Glenn JA, Else T, Hughes DT, Cohen MS, Jolly S, Giordano TJ, Worden FP, Gauger PG, Hammer GD, Miller BS. Surgery. 2019 Jan;165(1):186-195. doi: 10.1016/j.surg.2018.04.068. Epub 2018 Oct 19. PMID: 30343951
Outcomes After Adrenalectomy for Unilateral Primary Aldosteronism: An International Consensus on Outcome Measures and Analysis of Remission Rates in an International Cohort. Williams TA, Lenders JWM, Mulatero P, Burrello J, Rottenkolber M, Adolf C, Satoh F, Amar L, Quinkler M, Deinum J, Beuschlein F, Kitamoto KK, Pham U, Morimoto R, Umakoshi H, Prejbisz A, Kocjan T, Naruse M, Stowasser M, Nishikawa T, Young WF Jr, Gomez-Sanchez CE, Funder JW, Reincke M; Primary Aldosteronism Surgery Outcome (PASO) investigators. Lancet Diabetes Endocrinol. 2017 Sep;5(9):689-699. doi: 10.1016/S2213-8587(17)30135-3. Epub 2017 May 30. PMID: 28576687 Free PMC article.
Personalized Cared of Patients With Adrencortical Carcinoma: A Comprehensive Approach. Miller BS, Else T; AACE Adrenal Scientific Committee. Endocr Pract. 2017 Jun;23(6):705-715. doi: 10.4158/EP161719.RA. PMID: 28614035 Review.
Curative Surgical Resection of Adrenocortical Carcinoma: Determining Long-Term Outcome Based on Conditional Disease-Free Probability. Kim Y, Margonis GA, Prescott JD, Tran TB, Postlewait LM, Maithel SK, Wang TS, Glenn JA, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Poultsides GA, Pawlik TM. Ann Surg. 2017 Jan;265(1):197-204. doi: 10.1097/SLA.0000000000001527. PMID: 28009746 Free PMC article.
Outcomes After Resection of Cortisol-Secreting Adrenocortical Carcinoma. Margonis GA, Kim Y, Tran TB, Postlewait LM, Maithel SK, Wang TS, Glenn JA, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Poultsides GA, Pawlik TM. Am J Surg. 2016 Jun;211(6):1106-13. doi: 10.1016/j.amjsurg.2015.09.020. Epub 2015 Dec 31. PMID: 26810939 Free PMC article. Clinical Trial.
Novel Targeted Therapies in Adrenocortical Carcinoma. Konda B, Kirschner LS. Curr Opin Endocrinol Diabetes Obes. 2016 Jun;23(3):233-41. doi: 10.1097/MED.0000000000000247. PMID: 27119750 Free PMC article. Review.
Adrenocortical Carcinoma: Impact of Surgical Margin Status on Long-Term Outcomes. Margonis GA, Kim Y, Prescott JD, Tran TB, Postlewait LM, Maithel SK, Wang TS, Evans DB, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Poultsides GA, Pawlik TM. Ann Surg Oncol. 2016 Jan;23(1):134-41. doi: 10.1245/s10434-015-4803-x. Epub 2015 Aug 19. PMID: 26286195 Free PMC article. Clinical Trial.
Curative Resection of Adrenocortical Carcinoma: Rates and Patterns of Postoperative Recurrence. Amini N, Margonis GA, Kim Y, Tran TB, Postlewait LM, Maithel SK, Wang TS, Evans DB, Hatzaras I, Shenoy R, Phay JE, Keplinger K, Fields RC, Jin LX, Weber SM, Salem A, Sicklick JK, Gad S, Yopp AC, Mansour JC, Duh QY, Seiser N, Solorzano CC, Kiernan CM, Votanopoulos KI, Levine EA, Poultsides GA, Pawlik TM. Ann Surg Oncol. 2016 Jan;23(1):126-33. doi: 10.1245/s10434-015-4810-y. Epub 2015 Aug 18. PMID: 26282907 Free PMC article.
Radiographic Characteristics of Adrenal Masses Preceding the Diagnosis of Adrenocortical Cancer. Nogueira TM, Lirov R, Caoili EM, Lerario AM, Miller BS, Fragoso MC, Dunnick NR, Hammer GD, Else T. Horm Cancer. 2015 Aug;6(4):176-81. doi: 10.1007/s12672-015-0225-2. Epub 2015 May 29. PMID: 26021762
Adjuvant Radiation Therapy Improves Local Control After Surgical Resection in Patients With Localized Adrenocortical Carcinoma. Sabolch A, Else T, Griffith KA, Ben-Josef E, Williams A, Miller BS, Worden F, Hammer GD, Jolly S. Int J Radiat Oncol Biol Phys. 2015 Jun 1;92(2):252-9. doi: 10.1016/j.ijrobp.2015.01.007. Epub 2015 Mar 5. PMID: 25754631
Surgical Management of Adrenocortical Tumours. Miller BS, Doherty GM. Nat Rev Endocrinol. 2014 May;10(5):282-92. doi: 10.1038/nrendo.2014.26. Epub 2014 Mar 18. PMID: 24637859 Review.
Adrenocortical Carcinoma. Else T, Kim AC, Sabolch A, Raymond VM, Kandathil A, Caoili EM, Jolly S, Miller BS, Giordano TJ, Hammer GD. Endocr Rev. 2014 Apr;35(2):282-326. doi: 10.1210/er.2013-1029. Epub 2013 Dec 20. PMID: 24423978 Free PMC article. Review.
Adjuvant Therapies and Patient and Tumor Characteristics Associated With Survival of Adult Patients With Adrenocortical Carcinoma. Else T, Williams AR, Sabolch A, Jolly S, Miller BS, Hammer GD. J Clin Endocrinol Metab. 2014 Feb;99(2):455-61. doi: 10.1210/jc.2013-2856. Epub 2013 Dec 3. PMID: 24302750 Free PMC article.
Resection of Adrenocortical Carcinoma Is Less Complete and Local Recurrence Occurs Sooner and More Often After Laparoscopic Adrenalectomy Than After Open Adrenalectomy. Miller BS, Gauger PG, Hammer GD, Doherty GM. Surgery. 2012 Dec;152(6):1150-7. doi: 10.1016/j.surg.2012.08.024. PMID: 23158185
Targeted Therapies for Adrenocortical Carcinoma: IGF and Beyond. Demeure MJ, Bussey KJ, Kirschner LS. Horm Cancer. 2011 Dec;2(6):385-92. doi: 10.1007/s12672-011-0090-6. PMID: 22170383 Review.
Proposal for Modification of the ENSAT Staging System for Adrenocortical Carcinoma Using Tumor Grade. Miller BS, Gauger PG, Hammer GD, Giordano TJ, Doherty GM. Langenbecks Arch Surg. 2010 Sep;395(7):955-61. doi: 10.1007/s00423-010-0698-y. Epub 2010 Aug 9. PMID: 20694732
Laparoscopic Resection Is Inappropriate in Patients With Known or Suspected Adrenocortical Carcinoma. Miller BS, Ammori JB, Gauger PG, Broome JT, Hammer GD, Doherty GM. World J Surg. 2010 Jun;34(6):1380-5. doi: 10.1007/s00268-010-0532-2. PMID: 20372905
The Role of Radiologic Studies in the Evaluation and Management of Primary Hyperaldosteronism. White ML, Gauger PG, Doherty GM, Cho KJ, Thompson NW, Hammer GD, Miller BS. Surgery. 2008 Dec;144(6):926-33; discussion 933. doi: 10.1016/j.surg.2008.07.025. PMID: 19040999
Primary Hyperaldosteronism: Effect of Adrenal Vein Sampling on Surgical Outcome. Nwariaku FE, Miller BS, Auchus R, Holt S, Watumull L, Dolmatch B, Nesbitt S, Vongpatanasin W, Victor R, Wians F, Livingston E, Snyder WH 3rd. Arch Surg. 2006 May;141(5):497-502; discussion 502-3. doi: 10.1001/archsurg.141.5.497. PMID: 16702522